Aspen Neuroscience Announces Publication of Sasineprocel Preclinical Data in "Cell Stem Cell"Peer-reviewed findings describe reproducible manufacturing, leading-edge genomic quality controls and preclinical evidence supporting clinical development of an autologous iPSC-derived neuron replacement therapy for Parkinson’s disease, now entering Phase 3
